PMC:7696151 / 20119-20328 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"567","span":{"begin":6,"end":9},"obj":"Chemical"},{"id":"568","span":{"begin":122,"end":125},"obj":"Chemical"},{"id":"576","span":{"begin":164,"end":179},"obj":"Disease"}],"attributes":[{"id":"A567","pred":"tao:has_database_id","subj":"567","obj":"MESH:D011239"},{"id":"A568","pred":"tao:has_database_id","subj":"568","obj":"MESH:D006886"},{"id":"A576","pred":"tao:has_database_id","subj":"576","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"lone (PRD) in different combinations. Only 114 subjects remained until the end of the trial (six weeks). It was seen that HCQ had no benefit in the early stages of CHIKV infection and also in the reduction of "}

{"project":"LitCovid-sentences","denotations":[{"id":"T143","span":{"begin":38,"end":104},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"lone (PRD) in different combinations. Only 114 subjects remained until the end of the trial (six weeks). It was seen that HCQ had no benefit in the early stages of CHIKV infection and also in the reduction of "}